Bitterman Robert J.'s most recent trade in Phio Pharmaceuticals Corp was a trade of 2,000 Common Stock, $0.0001 par value done at an average price of $2.4 . Disclosure was reported to the exchange on June 10, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Phio Pharmaceuticals Corp | Robert J. Bitterman | Director, Chairman, Pres & CEO | Purchase of securities on an exchange or from another person at price $ 2.42 per share. | 10 Jun 2025 | 2,000 | 27,149 (1%) | 0% | 2.4 | 4,840 | Common Stock, $0.0001 par value |
| Phio Pharmaceuticals Corp | Robert J. Bitterman | Director, Chairman, Pres & CEO | Purchase of securities on an exchange or from another person at price $ 2.75 per share. | 09 Jun 2025 | 1,500 | 25,149 (1%) | 0% | 2.8 | 4,125 | Common Stock, $0.0001 par value |
| Phio Pharmaceuticals Corp | Robert J. Bitterman | Director, Chairman, Pres & CEO | Purchase of securities on an exchange or from another person at price $ 1.77 per share. | 21 May 2025 | 3,000 | 22,449 (1%) | 0% | 1.8 | 5,310 | Common Stock, $0.0001 par value |
| Phio Pharmaceuticals Corp | Robert J. Bitterman | Director, Chairman, Pres & CEO | Purchase of securities on an exchange or from another person at price $ 1.78 per share. | 21 May 2025 | 1,200 | 23,649 (1%) | 0% | 1.8 | 2,136 | Common Stock, $0.0001 par value |
| Phio Pharmaceuticals Corp | Robert J. Bitterman | Director, Chairman, Pres & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Sep 2024 | 15,500 | 17,832 (0%) | 0% | 0 | Common Stock, $0.0001 par value | |
| Phio Pharmaceuticals Corp | Robert J. Bitterman | Director, President & CEO | Purchase of securities on an exchange or from another person at price $ 0.74 per share. | 07 Jun 2024 | 1,000 | 20,990 (1%) | 0% | 0.7 | 740 | Common stock, $0.0001 par value |
| Phio Pharmaceuticals Corp | Robert J. Bitterman | Director, President & CEO | Purchase of securities on an exchange or from another person at price $ 0.75 per share. | 06 Jun 2024 | 1,000 | 19,990 (1%) | 0% | 0.8 | 750 | Common stock, $0.0001 par value |
| Phio Pharmaceuticals Corp | Bitterman Robert J. | Director, President & CEO | Purchase of securities on an exchange or from another person at price $ 0.91 per share. | 26 Feb 2024 | 2,500 | 18,990 (1%) | 0% | 0.9 | 2,275 | Common stock, $0.0001 par value |
| Phio Pharmaceuticals Corp | Bitterman J. Robert | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.76 per share. | 20 Feb 2024 | 1,804 | 16,490 (0%) | 0% | 0.8 | 1,371 | Common stock, $0.0001 par value |
| Phio Pharmaceuticals Corp | Robert J. Bitterman | Director, President & CEO | Purchase of securities on an exchange or from another person at price $ 2.84 per share. | 30 Jun 2023 | 1,000 | 19,211 (1%) | 0% | 2.8 | 2,840 | Common stock, $0.0001 par value |
| Phio Pharmaceuticals Corp | Robert J. Bitterman | Director, President & CEO | Purchase of securities on an exchange or from another person at price $ 2.88 per share. | 30 Jun 2023 | 1,000 | 18,211 (0%) | 0% | 2.9 | 2,880 | Common stock, $0.0001 par value |
| Phio Pharmaceuticals Corp | Robert J. Bitterman | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2023 | 11,000 | 17,211 (0%) | 0% | 0 | Common stock, $0.0001 par value | |
| Phio Pharmaceuticals Corp | Robert J. Bitterman | Director, Interim Executive Chairman | Purchase of securities on an exchange or from another person at price $ 0.39 per share. | 14 Dec 2022 | 2,000 | 74,541 (4%) | 0% | 0.4 | 780 | Common stock, $0.0001 par value |
| Phio Pharmaceuticals Corp | Robert J. Bitterman | Director, Interim Executive Chairman | Purchase of securities on an exchange or from another person at price $ 0.39 per share. | 07 Dec 2022 | 2,000 | 72,541 (3%) | 0% | 0.4 | 780 | Common stock, $0.0001 par value |
| Phio Pharmaceuticals Corp | Robert J. Bitterman | Director, Interim Executive Chairman | Purchase of securities on an exchange or from another person at price $ 0.43 per share. | 05 Dec 2022 | 2,000 | 70,541 (3%) | 0% | 0.4 | 860 | Common stock, $0.0001 par value |
| Phio Pharmaceuticals Corp | Robert J. Bitterman | Director, Interim Executive Chairman | Purchase of securities on an exchange or from another person at price $ 0.42 per share. | 25 Nov 2022 | 2,500 | 68,326 (3%) | 0% | 0.4 | 1,050 | Common stock, $0.0001 par value |
| Phio Pharmaceuticals Corp | Robert J. Bitterman | Director, Interim Executive Chairman | Purchase of securities on an exchange or from another person at price $ 0.40 per share. | 25 Nov 2022 | 215 | 68,541 (3%) | 0% | 0.4 | 86 | Common stock, $0.0001 par value |
| Phio Pharmaceuticals Corp | Robert J. Bitterman | Director, Interim Executive Chairman | Purchase of securities on an exchange or from another person at price $ 1750.00 per share. | 16 Nov 2022 | 1 | 1 | - | 1750 | 1,750 | Series D Preferred Stock, $0.0001 par value |
| Phio Pharmaceuticals Corp | Robert J. Bitterman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2022 | 40,000 | 65,826 (3%) | 2% | 0 | Common stock, $0.0001 par value | |
| Phio Pharmaceuticals Corp | Robert J. Bitterman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2022 | 10,000 | 25,826 (1%) | 0% | 0 | Common stock, $0.0001 par value | |
| Phio Pharmaceuticals Corp | Robert J. Bitterman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 10,000 | 15,826 (0%) | 0% | 0 | Common stock, $0.0001 par value |